Atlanta
Serologicals Corp. of Atlanta will decide the location of a second Ex-Cyte manufacturing facility by November 30. Several locations in the Midwest are being considered as the site of the $28-million plant. Completion is slated for the first half of 2004, with a 15 to 18 month construction period.
Serologicals provides biological products and technologies for the research, development, and manufacture of biologically-based life science products.
